P&T
Our
Other
Journal
MediMedia Managed Markets

 

Cangrelor Versus Clopidogrel in Intraprocedural Stent Thrombosis (IPST): CHAMPION PHOENIX

Cangrelor Versus Clopidogrel in Intraprocedural Stent Thrombosis (IPST): CHAMPION PHOENIX

Philippe Genereux, MD, of the Angiographic Core Laboratory, Cardiovascular Research Foundation in New York, NY, says that cangrelor was associated with significant reductions in the key endpoints of stent thrombosis and IPST when compared with clopidogrel.